Zepp Health (NYSE:ZEPP) Cut to “Sell” at Wall Street Zen

Wall Street Zen lowered shares of Zepp Health (NYSE:ZEPP) from a hold rating to a sell rating in a report released on Tuesday,Wall Street Zen reports.

Separately, Fundamental Research set a $53.01 price target on shares of Zepp Health and gave the company a “buy” rating in a report on Tuesday, August 11th. One investment analyst has rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $53.01.

Zepp Health Stock Performance

NYSE:ZEPP opened at $4.89 on Tuesday. Zepp Health has a 1 year low of $3.85 and a 1 year high of $61.85. The firm’s fifty day simple moving average is $5.06 and its 200 day simple moving average is $9.66. The company has a current ratio of 0.90, a quick ratio of 0.70 and a debt-to-equity ratio of 0.30. The firm has a market capitalization of $71.86 million, a PE ratio of -1.78 and a beta of 1.87.

Insider Activity at Zepp Health

In other news, CFO Cheng Deng sold 9,836 shares of the stock in a transaction that occurred on Friday, June 26th. The stock was sold at an average price of $4.61, for a total value of $45,343.96. Following the completion of the sale, the chief financial officer directly owned 114,539 shares of the company’s stock, valued at approximately $528,024.79. This represents a 7.91% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 36.00% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Zepp Health

Several hedge funds and other institutional investors have recently modified their holdings of ZEPP. Engineers Gate Manager LP grew its position in Zepp Health by 44.4% in the 2nd quarter. Engineers Gate Manager LP now owns 20,917 shares of the company’s stock worth $109,000 after purchasing an additional 6,433 shares during the last quarter. AXQ Capital LP bought a new stake in shares of Zepp Health in the second quarter valued at about $85,000. Millennium Management LLC lifted its stake in shares of Zepp Health by 49.1% in the fourth quarter. Millennium Management LLC now owns 366,826 shares of the company’s stock valued at $9,882,000 after buying an additional 120,750 shares during the period. Balyasny Asset Management L.P. grew its position in Zepp Health by 46.9% during the fourth quarter. Balyasny Asset Management L.P. now owns 202,775 shares of the company’s stock worth $5,463,000 after buying an additional 64,692 shares in the last quarter. Finally, FIL Ltd acquired a new stake in Zepp Health during the fourth quarter worth about $16,858,000. Institutional investors and hedge funds own 52.61% of the company’s stock.

About Zepp Health

Zepp Health Corp is a technology company specializing in the design, development and sale of smart wearable devices and health management solutions. Through its flagship Amazfit brand and the Zepp software ecosystem, the company offers a range of products—including smartwatches, fitness bands, smart scales and health-oriented mobile applications—designed to track key biometric data such as heart rate, sleep patterns, blood oxygen levels and activity metrics. Zepp Health’s integrated platform enables users to monitor wellness and fitness goals while leveraging cloud-based analytics for personalized insights.

At the core of Zepp Health’s offering is its Zepp cloud platform, which aggregates and analyzes data collected from its hardware lineup.